Winway Health Desk

FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin INCHEON, South Korea & JERUSALEM--(BUSINESS WIRE) December 14, 2018 --Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today...

As the Affordable Care Act open enrollment period for 2019 draws to a close, a number of factors have conspired to create what projects...

Posted on December 12th, 2018 by admin in Pharma R&D...

The Michael E. DeBakey VA Medical Center building in Houston comprises a vertical expansion and renovation to house the relocated Mental Health Clinic Trauma...

The possibility of a government investigation looms ever larger for Sun Pharma, as Indian regulators said they're indeed reviewing whistleblower allegations against the company....

Journey mapping has grown in popularity in healthcare planning because it can serve as a versatile tool to understand how and what provokes emotions...

Type 2 diabetes in older people can lead to increased memory loss and verbal fluency, but this is not directly associated with...

After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters...

In an interview on CNBC’s “Squawk on the Street” earlier this week, former athenahealth CEO Jonathan Bush criticized Elliott Management, the activist investor that took...

The US Food and Drug Administration (FDA) has warned companies that attempt to block cheaper biosimilar alternatives from being made available in...